查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585663

生物过程分析仪市场：按类型、应用和最终用户划分 - 2025-2030 年全球预测

Bioprocess Analyzers Market by Type (Consumables & Accessories, Instruments), Application (Antibiotics, Biosimilars, Recombinant Proteins), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年生物过程分析仪市值为5.2167亿美元，预计到2024年将达到5.8142亿美元，复合年增长率为11.54%，预计到2030年将达到11.2104亿美元。

生物製程分析仪是生物製药製造中使用的关键仪器，透过监测 pH、溶解氧和细胞密度等变数来确保产品品质和一致性。严格的监管要求和生物製程技术日益复杂性加剧了对这些分析仪的需求。应用于生物製药、食品饮料、环境等领域的研发、製程监控及品管。最终用途范围包括生物製造、研究实验室和致力于优化产量并遵守良好生产规范 (GMP) 的製药公司。市场成长的推动因素是慢性病的增加对生技药品的需求增加以及製程分析技术的改进所带来的技术进步。新兴市场的生物製药基础设施不断扩大、个人化医疗的出现以及一次性技术的日益增长趋势提供了可行的机会。然而，初始成本高、对熟练人员的需求以及整合的复杂性等挑战是主要障碍。为了利用成长机会，公司应专注于即时和现场分析解决方案的创新、提高自动化程度以及减少製程监控中人为干预的解决方案。利用人工智慧和机器学习的增强型资料分析工具还可以提供更深入的见解和预测能力，推动更主动的流程最佳化。该市场充满活力且竞争激烈，其特点是生物製药公司与技术供应商之间的大量研发投资以及合作伙伴关係。值得注意的创新领域包括开发整合各种分析功能的多功能分析仪以及可提高操作灵活性的可携式、使用者友善分析仪。儘管存在挑战，生物加工产能的持续成长以及更环保、更永续的生产流程的趋势仍然是推动市场向前发展的影响因素，企业准备为全球永续性做出贡献，这强调了关注环保解决方案的重要性。

主要市场统计
基准年[2023] 5.2167 亿美元
预测年份 [2024] 5.8142亿美元
预测年份 [2030] 1,121,040,000 美元
复合年增长率（%） 11.54%

市场动态：快速发展的生物过程分析仪市场的关键市场洞察

供需的动态交互作用正在改变生物过程分析仪市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 对先进生物加工技术的需求不断增长
    • 治疗和药物需求迅速增加
    • 对医用重组蛋白的需求不断增长
  • 市场限制因素
    • 原料成本上涨
  • 市场机会
    • 综合分析设备技术进步
    • 生物技术研究的增加
  • 市场挑战
    • 与下游生物加工相关的复杂性

波特五力：驾驭生物过程分析仪市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解生物过程分析仪市场的外部影响

外部宏观环境因素在塑造生物过程分析仪市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解生物过程分析仪市场的竞争状况

对生物过程分析仪市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵生物过程分析仪市场供应商的绩效评估

FPNV 定位矩阵是评估生物製程分析仪市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划生物过程分析仪市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，生物过程分析仪市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对先进生物加工技术的需求不断增长
      • 对治疗和药物的需求迅速增加
      • 医用重组蛋白的需求增加
    • 抑制因素
      • 原料成本上涨
    • 机会
      • 整合分析仪的技术进步
      • 生物技术研究的增加
    • 任务
      • 与下游生物过程相关的复杂性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章生物过程分析仪市场：依类型

  • 耗材及配件
  • 装置

第七章生物过程分析仪市场：依应用分类

  • 抗生素
  • 生物相似药
  • 重组蛋白

第八章生物过程分析仪市场：依最终用户分类

  • 生物製药公司
  • 契约製造组织
  • 合约调查机构

第九章美洲生物过程分析仪市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太生物製程分析仪市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲/中东/非洲生物过程分析仪市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Agilent Technologies, Inc.
  • Aligned Genetics, Inc.
  • F. Hoffmann-La Roche AG
  • Fluorometrics Instruments, LLC by AlpHa Measurement Solutions LLC
  • Groton Biosystems, LLC
  • Kaiser Optical Systems, Inc.
  • Nova Biomedical Corporation
  • Polestar Technologies, Inc.
  • PreSens Precision Sensing GmbH
  • Randox Laboratories Ltd
  • Shimadzu Corporation
  • SYSBIOTECH GmbH
  • The Sartorius Group
  • Thermo Fisher Scientific Inc.
  • YSI, Inc.
Product Code: MRR-437D45957B0E

The Bioprocess Analyzers Market was valued at USD 521.67 million in 2023, expected to reach USD 581.42 million in 2024, and is projected to grow at a CAGR of 11.54%, to USD 1,121.04 million by 2030.

Bioprocess analyzers are critical instruments utilized in biopharmaceutical manufacturing to ensure the product's quality and consistency by monitoring variables like pH, dissolved oxygen, and cell density. The necessity of these analyzers is underscored by the stringent regulatory requirements and the growing complexity of bioprocessing techniques. They find applications in research and development, process monitoring, and quality control across the biopharmaceutical, food and beverage, and environmental sectors. The end-use scope includes biomanufacturing industries, research laboratories, and pharmaceutical companies committed to optimizing yields and complying with Good Manufacturing Practices (GMP). The market growth is notably driven by the increasing prevalence of chronic diseases, prompting higher demand for biologics, and technological advancements offering enhanced process analytical techniques. Emerging markets with expanding biopharmaceutical infrastructure, the advent of personalized medicine, and the growing trend of single-use technologies present viable opportunities. However, challenges such as high initial costs, the need for skilled personnel, and integration complexities pose significant barriers. To capitalize on growth opportunities, companies should focus on innovation in real-time and in-situ analytical solutions, increasing automation, and solutions that reduce human intervention in process monitoring. Enhanced data analytics tools that leverage AI and machine learning can also provide deeper insights and predictive capabilities, fostering more proactive process optimization. The market is dynamic and highly competitive, characterized by significant R&D investments and collaborations between biopharmaceutical firms and technology providers. Notable areas for innovation include developing multifunctional analyzers that integrate various analytical capabilities and portable and user-friendly analyzers for improved operational flexibility. Despite challenges, the continuous growth in bioprocessing capacity and the trend towards greener and more sustainable production processes remain influential factors that drive the market forward, highlighting the importance for companies to focus on eco-friendly solutions to align with global sustainability initiatives.

KEY MARKET STATISTICS
Base Year [2023] USD 521.67 million
Estimated Year [2024] USD 581.42 million
Forecast Year [2030] USD 1,121.04 million
CAGR (%) 11.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bioprocess Analyzers Market

The Bioprocess Analyzers Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising need for advanced bioprocess technology
    • Surge in the need for therapeutic treatment and medicines
    • Growing demand for recombinant proteins for medical applications
  • Market Restraints
    • High cost of raw materials
  • Market Opportunities
    • Technological advancement in the integrated analyzers
    • Increasing research in biotechnology
  • Market Challenges
    • Complexities associated with downstream bioprocess

Porter's Five Forces: A Strategic Tool for Navigating the Bioprocess Analyzers Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bioprocess Analyzers Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bioprocess Analyzers Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bioprocess Analyzers Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bioprocess Analyzers Market

A detailed market share analysis in the Bioprocess Analyzers Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bioprocess Analyzers Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bioprocess Analyzers Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bioprocess Analyzers Market

A strategic analysis of the Bioprocess Analyzers Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bioprocess Analyzers Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Aligned Genetics, Inc., F. Hoffmann-La Roche AG, Fluorometrics Instruments, LLC by AlpHa Measurement Solutions LLC, Groton Biosystems, LLC, Kaiser Optical Systems, Inc., Nova Biomedical Corporation, Polestar Technologies, Inc., PreSens Precision Sensing GmbH, Randox Laboratories Ltd, Shimadzu Corporation, SYSBIOTECH GmbH, The Sartorius Group, Thermo Fisher Scientific Inc., and YSI, Inc..

Market Segmentation & Coverage

This research report categorizes the Bioprocess Analyzers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Consumables & Accessories and Instruments.
  • Based on Application, market is studied across Antibiotics, Biosimilars, and Recombinant Proteins.
  • Based on End User, market is studied across Biopharmaceutical Companies, Contract Manufacturing Organizations, and Contract Research Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising need for advanced bioprocess technology
      • 5.1.1.2. Surge in the need for therapeutic treatment and medicines
      • 5.1.1.3. Growing demand for recombinant proteins for medical applications
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of raw materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in the integrated analyzers
      • 5.1.3.2. Increasing research in biotechnology
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities associated with downstream bioprocess
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bioprocess Analyzers Market, by Type

  • 6.1. Introduction
  • 6.2. Consumables & Accessories
  • 6.3. Instruments

7. Bioprocess Analyzers Market, by Application

  • 7.1. Introduction
  • 7.2. Antibiotics
  • 7.3. Biosimilars
  • 7.4. Recombinant Proteins

8. Bioprocess Analyzers Market, by End User

  • 8.1. Introduction
  • 8.2. Biopharmaceutical Companies
  • 8.3. Contract Manufacturing Organizations
  • 8.4. Contract Research Organizations

9. Americas Bioprocess Analyzers Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Bioprocess Analyzers Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Bioprocess Analyzers Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Aligned Genetics, Inc.
  • 3. F. Hoffmann-La Roche AG
  • 4. Fluorometrics Instruments, LLC by AlpHa Measurement Solutions LLC
  • 5. Groton Biosystems, LLC
  • 6. Kaiser Optical Systems, Inc.
  • 7. Nova Biomedical Corporation
  • 8. Polestar Technologies, Inc.
  • 9. PreSens Precision Sensing GmbH
  • 10. Randox Laboratories Ltd
  • 11. Shimadzu Corporation
  • 12. SYSBIOTECH GmbH
  • 13. The Sartorius Group
  • 14. Thermo Fisher Scientific Inc.
  • 15. YSI, Inc.

LIST OF FIGURES

  • FIGURE 1. BIOPROCESS ANALYZERS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPROCESS ANALYZERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BIOPROCESS ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BIOPROCESS ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BIOPROCESS ANALYZERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BIOPROCESS ANALYZERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BIOPROCESS ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BIOPROCESS ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BIOPROCESS ANALYZERS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BIOPROCESS ANALYZERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPROCESS ANALYZERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPROCESS ANALYZERS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY BIOSIMILARS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPROCESS ANALYZERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BIOPROCESS ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES BIOPROCESS ANALYZERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC BIOPROCESS ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BIOPROCESS ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM BIOPROCESS ANALYZERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM BIOPROCESS ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM BIOPROCESS ANALYZERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. BIOPROCESS ANALYZERS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. BIOPROCESS ANALYZERS MARKET, FPNV POSITIONING MATRIX, 2023